Alan Brochstein

GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) made history Monday when the company’s Epidiolex became the first cannabis-based drug ever approved by the FDA. New Cannabis Ventures and 420 Investor founder Alan Brochstein joined the PreMarket Prep trading show on Tuesday to discuss the...

Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited—get your tickets before they sell out. Ahead of the...

4/20 is here, and in time for International Weed Day, Senate Minority Leader Chuck Schumer (D-N.Y.) announced plans to introduce a bill to decriminalize cannabis on a federal level next week. “The war on cannabis costs U.S. taxpayers $3.6 billion per year. 46 percent of all drug arrests are...

Two words summarize last week’s most relevant event for the cannabis industry: John Boehner. The former House speaker announced his views on cannabis had evolved and, in support of legalization, he was joining the board of directors of New York-based marijuana company Acreage Holdings. To...

April started with considerable pressure on the markets. “Concerns over legalization in Canada, previously assumed to be a ‘done deal,’ continue to weigh on investors, along with fears of a supply glut, as discussed on the cover of Barron’s this week,” 420 Investor...

A shortened week didn't stop the action in the cannabis industry. Several big deals were announced last week, including CannaRoyalty Corp (OTC: CNNRF)’s purchase of RVR in an all-stock deal, GB Sciences Inc (OTC: GBLX)’s acquisition of a Nevada operation for all cash, and Liberty...

It was a turbulent week for cannabis stocks in the U.S., however, it was Canadian equities that experienced the most volatility, largely due to the publication of Health Canada’s document on legal cannabis packaging, marketing and retail, and the later vote of Bill C-45, also known as ...

This was a strange week for cannabis stocks, as major indices experienced a plateau, spiking Tuesday and tumbling Thursday. The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., ended the week down 4.1 percent, while the North American Marijuana Index,...

Cannabis stocks seem to be rebounding after a tough February. Over the last week, the United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., posted gains of 5.5 percent. Meanwhile, the North American Marijuana Index, was a bit more volatile on the back of...

Despite a strong performance Friday, U.S. cannabis stocks had a bad week, with the United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., losing roughly 4 percent of its value. The North American Marijuana Index, which also includes Canadian stocks, shed...

The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., lost 7.5 percent in the four days the market was open after President's Day. The North American Marijuana Index, which also includes Canadian stocks, shed 4 percent of its value. The Horizons...

After a relatively stable few days, cannabis stocks returned to the red Thursday. The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., ended the week almost flat. The North American Marijuana Index, which also includes Canadian stocks, lost 5.6 percent...

Despite Friday’s rebound, this was a bad week for the U.S. stock market. Cannabis stocks followed a very different trajectory, with the United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., posting a loss of 2.34 percent Friday, but still closing the week...

The Great Lakes State has the second-largest medical marijuana patient base in the country, trailing only gigantic California. A shift in Michigan's medical marijuana market is no small event. Major legal weed markets have opened up on the West Coast — California, Washington, Oregon,...

North American cannabis stocks took a beating this week, with the North American Marijuana Index posting a 27.2 percent loss, largely on the back of poor performance among Canadian stocks. "The Canadian market collapsed this week after over $1.2 billion of deal offerings from publicly-traded...